| Carrie L Dul, MD | |
|
19229 Mack Ave Ste 24, Grosse Pointe Woods, MI 48236-2857 | |
| (313) 884-5522 | |
| (313) 884-5521 |
| Full Name | Carrie L Dul |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 25 Years |
| Location | 19229 Mack Ave Ste 24, Grosse Pointe Woods, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003820648 | NPI | - | NPPES |
| 0824230 | Other | MI | BCN |
| 0H208910 | Other | MI | BLUE CROSS |
| 4751900 | Medicaid | MI | |
| 4751928 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | CD084925 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension St John Hospital | 3173424082 | 296 |
News Archive
In less than 3 months, life-saving albuterol inhalers used by nearly 40 million patients with respiratory disorders will no longer be sold.
According to the American Diabetes Association, diabetes affects as many as 21 million Americans increasing their risk of heart attacks, kidney disease and blindness.
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.
› Verified 2 days ago
| Entity Name | Ascension St John Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043478910 PECOS PAC ID: 3173424082 Enrollment ID: O20040115000409 |
News Archive
In less than 3 months, life-saving albuterol inhalers used by nearly 40 million patients with respiratory disorders will no longer be sold.
According to the American Diabetes Association, diabetes affects as many as 21 million Americans increasing their risk of heart attacks, kidney disease and blindness.
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.
› Verified 2 days ago
| Entity Name | Ascension Medical Group Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114133485 PECOS PAC ID: 0648180406 Enrollment ID: O20081015000289 |
News Archive
In less than 3 months, life-saving albuterol inhalers used by nearly 40 million patients with respiratory disorders will no longer be sold.
According to the American Diabetes Association, diabetes affects as many as 21 million Americans increasing their risk of heart attacks, kidney disease and blindness.
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie L Dul, MD 19229 Mack Ave Ste 24, Grosse Pointe Woods, MI 48236-2857 Ph: (313) 884-5522 | Carrie L Dul, MD 19229 Mack Ave Ste 24, Grosse Pointe Woods, MI 48236-2857 Ph: (313) 884-5522 |
News Archive
In less than 3 months, life-saving albuterol inhalers used by nearly 40 million patients with respiratory disorders will no longer be sold.
According to the American Diabetes Association, diabetes affects as many as 21 million Americans increasing their risk of heart attacks, kidney disease and blindness.
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.
› Verified 2 days ago
Mamta Sharma, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19251 Mack Ave, Grosse Pointe Woods, MI 48236 Phone: 313-343-7280 Fax: 313-343-7921 | |
Ayad M. Al-katib, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 19229 Mack Ave, Suite 34, Grosse Pointe Woods, MI 48236 Phone: 313-647-3245 Fax: 313-647-3244 | |
Dr. Ashish Bhargava, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19251 Mack Ave Ste 333, Grosse Pointe Woods, MI 48236 Phone: 313-343-7280 Fax: 313-343-7921 | |
Dr. Ronald D Hertz, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19251 Mack Ave, Grosse Pointe Woods, MI 48236 Phone: 313-343-3749 Fax: 313-343-7921 | |
Thomas Joseph Loss, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 19299 Mack Ave Ste 34, Grosse Pointe Woods, MI 48236 Phone: 313-647-3245 Fax: 313-647-3244 | |
Zyad Kafri, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19229 Mack Ave, Suite 23, Grosse Pointe Woods, MI 48236 Phone: 313-647-3245 Fax: 313-647-3244 |